GlobeNewswire 2025-12-23 Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thromb...
GlobeNewswire 2025-12-23 Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
GlobeNewswire 2025-12-23 Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years wit...
GlobeNewswire 2025-12-19 Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengt...
GlobeNewswire 2025-12-17 Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive...
GlobeNewswire 2025-12-17 Press release: Availability of the Q4 2025 Aide memoire
GlobeNewswire 2025-12-17 Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin ...
GlobeNewswire 2025-12-16 NodThera Appoints Geoff McDonough, M.D., as Independent Board Member
GlobeNewswire 2025-12-16 Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Ora...
GlobeNewswire 2025-12-15 Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
GlobeNewswire 2025-12-15 Press Release : Sanofi provides update on tolebrutinib regulatory submission in non-relapsing second...
GlobeNewswire 2025-12-11 Prolynx Secures $70 Million Series A to Advance Portfolio of Ultra-Long-Acting Obesity Candidates an...
GlobeNewswire 2025-12-11 Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
Newsfile Corp 2025-12-09 TMX Group Equity Financing Statistics - November 2025
GlobeNewswire 2025-12-08 Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström...
GlobeNewswire 2025-12-07 Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive R...
GlobeNewswire 2025-12-06 Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of ...
GlobeNewswire 2025-12-04 Press Release: Sanofi completes acquisition of Vicebio
GlobeNewswire 2025-12-02 Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy ...
GlobeNewswire 2025-12-02 Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
GlobeNewswire 2025-12-01 Altimmune Announces CEO Transition and Succession Plan
GlobeNewswire 2025-12-01 Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial ...
GlobeNewswire 2025-12-01 Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Ther...
GlobeNewswire 2025-12-01 Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Ther...
GlobeNewswire 2025-11-26 Valneva to Further Consolidate its Operations in France